ArticleJournal of managed care & specialty pharmacy2020

Time to Next Treatment, Health Care Resource Utilization, and Costs Associated with Ibrutinib Use Among U.S. Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Retrospective Analysis.

Qing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.